[ T able_StockInfo] 2025 年 09 月 12 日 证券研究报告•2025 年中报点评 中牧股份（600195）农林牧渔 目标价：8.96 元（6 个月） 买入 （上调） 当前价：7.42 元 业绩显著修复，宠物业务与研发驱动新增长 | [Table_MainProfit] 指标/年度 | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业收入（百万元） | 6,017 | 6,569 | 7,190 | 7,798 | | 增长率 | 11.30% | 9.17% | 9.46% | 8.46% | | 归属母公司净利润（百万元） | 71 | 287 | 351 | 386 | | 增长率 | -82.41% | 305.33% | 22.12% | 9.99% | | 每股收益 EPS（元） | 0.07 | 0.28 | 0.34 | 0.38 | | 净资产收益率 ROE | 1.29% | 5.03% | 5.90% | 6.22% | | PE | 96.69 | 26.37 | 21.6 ...

Summary of Conference Call Industry and Company Involved - The conference call primarily discusses the **agriculture industry**, focusing on the **pet sector** and **livestock farming**, particularly **swine farming** and **pet medical care**. Key Points and Arguments Pet Sector 1. The company has been continuously recommending the **pet sector**, with a recent emphasis on the **breeding sector** as well. The focus includes **pet food** and **pet medical care** [1][8] 2. Recent offline surveys indicate a shift in the pet market towards **fresh food** and **differentiated products**, highlighting the competitive landscape driven by product innovation [9][10] 3. The pet market is currently characterized by high marketing costs and increased competition, necessitating a focus on product quality and consumer education [13][14] 4. Domestic leading brands are gaining traction, particularly in the mid to high-end market segments, despite facing competition from foreign brands [15][16] Livestock Farming 5. The company has started to recommend the **swine farming sector** due to favorable market conditions and stable pig prices, which have remained between **14 to 15 yuan** per kilogram since the Chinese New Year [3][4] 6. There has been a significant increase in the average weight of pigs post-Chinese New Year, with an increase of nearly **8 kilograms**, indicating a positive trend in livestock growth [4] 7. Despite the current stability, there is a bearish outlook on pig prices due to high supply pressures, presenting a potential buying opportunity in the livestock sector [6] Pet Medical Care 8. The pet medical care sector is viewed as having substantial growth potential, with expectations for the market to develop into a **billion-dollar industry** [18][19] 9. The domestic pet medical market is still in its early stages compared to mature markets like the U.S., indicating significant room for growth in pet health management and spending [19] 10. Companies with strong R&D capabilities and a focus on pet vaccines and pharmaceuticals are expected to thrive in the evolving market landscape [20][22] Financial Performance and Projections 11. The company anticipates a **20%** growth rate over the next two to three years, supported by the launch of new products in the pet medical sector [24] 12. Current valuations suggest that the company is trading at less than **18 times** earnings, indicating a favorable investment opportunity [24] Additional Insights 13. Recent policy changes are expected to accelerate trends in the livestock sector, with ongoing adjustments in regulations impacting market dynamics [6][7] 14. The competitive landscape in the pet food market is shifting towards product-driven strategies, with an emphasis on health and premium offerings [11][12] Conclusion The conference call highlights a positive outlook for both the pet and livestock sectors, driven by product innovation, market stability, and favorable growth projections. The emphasis on R&D and adapting to consumer trends is crucial for companies operating in these industries.

Summary of Conference Call on Pet Industry and Companies Industry Overview - The pet industry is experiencing rapid growth, with an annual compound growth rate of approximately 10% driven by increasing pet ownership and the rising penetration of pet food products [2][10] - The pet medical market is projected to reach 80-90 billion by 2025, making it the second-largest segment after pet food [10] Key Companies and Their Performance 1. Guibao Pet - Guibao Pet's self-owned brand has shown strong performance, with revenue of approximately 3.5 billion, accounting for nearly 70% of total revenue, and a net profit margin of 12% [1][4] - The high-end cat food brand, Fliegate, achieved a growth rate of 100% last year and maintained the same growth rate in Q1 of this year [4] - Guibao is expected to become a leading enterprise with projected revenues nearing 25 billion and net profits around 5 billion in the medium to long term [1][4] 2. Zhongchong Co., Ltd. - Zhongchong Co., Ltd. experienced a significant growth of nearly 200%-300% from its previous low, with total revenue from its three domestic brands (Wangpi, Lingxian, and ZIP) reaching 1.4 billion last year [5] - The company aims for overseas revenue of 400 million this year, maintaining a growth rate of 50% [5][6] - The net profit margin for its North American subsidiary is reported to be between 15%-20% [6] 3. Petty Co., Ltd. - Petty's overseas business accounts for a significant portion of its operations, with a focus on exports to the U.S. [8] - Domestic revenue was approximately 290 million last year, with a target of 400-450 million this year, reflecting a growth of over 40% [9] - The company is adjusting its product lines and plans to launch new baked grain products in Q2 and Q3 [8][9] Market Dynamics and Future Outlook - The pet medical sector is characterized by a lack of dominant players, with foreign brands leading in pharmaceuticals and vaccines, indicating substantial room for domestic companies to grow [11][12] - The average medical expenses for pets have doubled due to increasing age, leading to a rigid demand for medical services [10] - Companies like Ruipuhua and KQ Bio are recommended for their comprehensive industry layouts and potential for growth in the pet medical field [13][15] Additional Insights - The overall pet industry is expected to continue expanding, with self-owned brands focusing on product innovation to enhance profitability [2] - The competitive landscape in the pet medical sector is still developing, with many local companies poised to capture market share as the industry matures [12] - Other companies to watch include Baisha Technology, Biological Shares, and Zhongmu Shares, which have varying degrees of involvement in the pet medical sector [18]

1 、 《 PEEK材料产业链梳理，下一个千亿级赛道？ 》摘要 ■ PEEK的自润滑性和耐高温性能使其成为机器人驱动系统中的理想材料，减少摩擦和噪音，延长使 用寿命。 ■ 由于其优异的耐热、绝缘及耐腐蚀性，PEEK适合用于电子设备的支撑结构，尤其是在特殊环境下 工作的机器人中，如医疗和航天机器人。 ■ PEEK的核心原料是二氟二苯甲酮（DFBP），这类原料的生产技术掌握在少数企业手中，全球产能 集中度高。 2、 《 宠物经济虽热，难掩动物保健行业颓势 》摘要 ■ 2024年中国的宠物市场规模预计突破3000亿元，且宠物用药对安全性和有效性有更高要求，尤其 是猫三联和犬四联疫苗的国产化进程正在加速。 ■ 瑞普生物在宠物用疫苗领域表现突出，特别是打破了进口品牌对猫三联疫苗的垄断，取得了一定的 市场份额。 ■ 大型养殖集团如温氏股份、牧原股份等已经开始布局兽药和疫苗业务，这使得独立的动物保健企业 面临着前所未有的压力。 ■ 随着大型养殖企业自建兽药产能，并通过集中采购提高议价能力，独立兽药公司的市场空间将被进 一步压缩。 3、 《 关税战，先把宠物经济"打爆了" 》摘要 ■ 乖宝宠物通过高效的成本管控和规模效应，推 ...